Supplementary Figure S8 from BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance

<p>Supplementary Figure S8 shows T cell-priming by adoptively transferred cDC1 cells, their T-cell dependent cancer-regressing effect, as well as sensitization to PD-1 blockade.</p>